Drug recall

Treanda (bendamustine HCl) for Injection, 25 mg/vial, lyophilized powder in a Single Use Vial, Rx Only…

FDA recall event 61511 · Class III · Cephalon, Inc.

Key facts

Event ID 61511
Recall numbers D-1308-2012
Recalling firm Cephalon, Inc.
Product type Drugs
Products Treanda (bendamustine HCl) for Injection, 25 mg/vial, lyophilized powder in a Single Use Vial, Rx Only, Manufactured for: Cephalon Inc., Frazer, PA 19355, NDC 63459-390-08, UPC 3 63459 390 08 6.
Classification Class III
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Impurities/Degradation Products: Product is being recalled due to an Out of Specification result for an impurity in Lot Number TB30411 of Treanda(R) 25 mg (8 mL vial).
Initiation date Mar 15, 2012
Termination date Apr 2, 2013
City Malvern
State PA
Country United States
FEI number 1000307054

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports

Browse all FDA drug and product recalls